Investors / Lilly Asia Ventures / Compare with RA Capital

Lilly Asia Ventures vs RA Capital

Lilly Asia Ventures lists 60 portfolio companies and has joined 15 funding rounds; RA Capital lists 217 companies and has joined 64 rounds. Lilly Asia Ventures comes in most often at Series B (57% of its entries), RA Capital comes in most often at Growth (39% of its entries). 8 companies are on both portfolios, among them Black Diamond Therapeutics, Connect Biopharma and Inhibrx.

Lilly Asia VenturesView profilevsRA CapitalView profile

60Portfolio companies217

15Funding rounds joined64

3Rounds led25

11Rounds, last 12 months46

$20M to $100MTypical round it comes in at$100M or more

0%Sites no longer answering0%

Show as a table

Lilly Asia Ventures and RA Capital, head to head

	Lilly Asia Ventures	RA Capital
Portfolio companies	60	217
Funding rounds joined	15	64
Rounds led	3	25
Rounds, last 12 months	11	46
Typical round it comes in at	$20M to $100M	$100M or more
Sites no longer answering	0%	0%

Companies both back

8

Black Diamond Therapeuticsblackdiamondtherapeutics.comConnect Biopharmaconnectbiopharm.comInhibrxinhibrx.comLegend Biolegendbiotech.comNiKang Therapeuticsnikangtx.comPinnacle Medicinespinnaclemedicines.comProfoundBioprofoundbio.comVerdiva Bioverdivabio.com

Shared companies are those both firms' own portfolio pages list, each checked against the company's site. The same comparison through the API is POST /v1/overlap, for up to 20 firms. How the data is graded

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/lavfund.com/portfolio

# also
GET /v1/firms/racap.com/portfolio
GET /v1/firms/lavfund.com/coinvestors